<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Transl Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Transl Psychiatry</journal-id>
<journal-title-group>
<journal-title>Translational Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">2158-3188</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30710087</article-id>
<article-id pub-id-type="pmc">6358611</article-id>
<article-id pub-id-type="publisher-id">354</article-id>
<article-id pub-id-type="doi">10.1038/s41398-018-0354-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Risk gene-set and pathways in 22q11.2 deletion-related schizophrenia: a genealogical molecular approach</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Michaelovsky</surname>
<given-names>Elena</given-names>
</name>
<address>
<phone>972-3-9376787</phone>
<phone>972-54-5480779</phone>
<email>michaelo@tauex.tau.ac.il</email>
<email>elenami2@clalit.org.il</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Carmel</surname>
<given-names>Miri</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frisch</surname>
<given-names>Amos</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7272-0846</contrib-id>
<name>
<surname>Salmon-Divon</surname>
<given-names>Mali</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pasmanik-Chor</surname>
<given-names>Metsada</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weizman</surname>
<given-names>Abraham</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gothelf</surname>
<given-names>Doron</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0546</institution-id><institution-id institution-id-type="GRID">grid.12136.37</institution-id><institution>Sackler Faculty of Medicine, </institution><institution>Tel Aviv University, </institution></institution-wrap>Tel Aviv, Israel </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0546</institution-id><institution-id institution-id-type="GRID">grid.12136.37</institution-id><institution>Felsenstein Medical Research Center, </institution></institution-wrap>Petah Tikva, Israel </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9824 6981</institution-id><institution-id institution-id-type="GRID">grid.411434.7</institution-id><institution>Department of Molecular Biology, </institution><institution>Ariel University, </institution></institution-wrap>Ariel, Israel </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0546</institution-id><institution-id institution-id-type="GRID">grid.12136.37</institution-id><institution>Bioinformatics Unit, G.S. Wise Faculty of Life Science, </institution><institution>Tel Aviv University, </institution></institution-wrap>Tel Aviv, Israel </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0403 0450</institution-id><institution-id institution-id-type="GRID">grid.415340.7</institution-id><institution>Geha Mental Health Center, </institution></institution-wrap>Petah Tikva, Israel </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0546</institution-id><institution-id institution-id-type="GRID">grid.12136.37</institution-id><institution>Sagol School of Neuroscience, </institution><institution>Tel Aviv University, </institution></institution-wrap>Tel Aviv, Israel </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 2845</institution-id><institution-id institution-id-type="GRID">grid.413795.d</institution-id><institution>The Behavioral Neurogenetics Center, </institution><institution>Sheba Medical Center, </institution></institution-wrap>Tel Hashomer, Israel </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>17</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>9</volume>
<elocation-id>15</elocation-id>
<history>
<date date-type="received">
<day>3</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>5</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">The 22q11.2 deletion is a strong, but insufficient, “first hit” genetic risk factor for schizophrenia (SZ). We attempted to identify “second hits” from the entire genome in a unique multiplex 22q11.2 deletion syndrome (DS) family. Bioinformatic analysis of whole-exome sequencing and comparative-genomic hybridization array identified de novo and inherited, rare and damaging variants, including copy number variations, outside the 22q11.2 region. A specific 22q11.2-haplotype was associated with psychosis. The interaction of the identified “second hits” with the 22q11.2 haploinsufficiency may affect neurodevelopmental processes, including neuron projection, cytoskeleton activity, and histone modification in 22q11.2DS-ralated psychosis. A larger load of variants, involved in neurodevelopment, in combination with additional molecular events that affect sensory perception, olfactory transduction and G-protein-coupled receptor signaling may account for the development of 22q11.2DS-related SZ. Comprehensive analysis of multiplex families is a promising approach to the elucidation of the molecular pathophysiology of 22q11.2DS-related SZ with potential relevance to treatment.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000874</institution-id>
<institution>Brain and Behavior Research Foundation (Brain &amp; Behavior Research Foundation)</institution>
</institution-wrap>
</funding-source>
<award-id>22597</award-id>
<award-id>22597</award-id>
<award-id>22597</award-id>
<principal-award-recipient>
<name>
<surname>Michaelovsky</surname>
<given-names>Elena</given-names>
</name>
<name>
<surname>Frisch</surname>
<given-names>Amos</given-names>
</name>
<name>
<surname>Weizman</surname>
<given-names>Abraham</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100006221</institution-id>
<institution>United States - Israel Binational Science Foundation (BSF)</institution>
</institution-wrap>
</funding-source>
<award-id>2011378</award-id>
<principal-award-recipient>
<name>
<surname>Gothelf</surname>
<given-names>Doron</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000025</institution-id>
<institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
</institution-wrap>
</funding-source>
<award-id>U01MH101722</award-id>
<principal-award-recipient>
<name>
<surname>Gothelf</surname>
<given-names>Doron</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Schizophrenia (SZ) is a disabling mental disorder affecting 1% of the general population with a strong genetic component. Case–control studies of thousands participants have identified many molecular variants carrying genetic risk for SZ<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref></sup>. The highest known genetic risk for SZ is the 22q11.2 microdeletion<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Individuals carrying a hemizygous 22q11.2 deletion, “first hit”, have ~40% chance of developing SZ-spectrum disorders in adults<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>.</p>
<p id="Par3">Since not all individuals who carry the 22q11.2 deletion develop SZ, it is plausible that genetic variants outside the 22q11.2 region (“second hits”) contribute to the risk to develop SZ<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. In an attempt to identify genetic risk factors contributing to SZ development, we focused on a large multiplex 22q11.2DS family. Studying multiplex families is a promising approach since the risk variants in the SZ affected individuals are expected to be enriched compared to the non-affected family members. A genealogical analysis, in contrast to case–control study, eliminates the need for population stratification. Moreover, it is a straightforward and less expensive strategy to analyze the association between clinical and genetic data in a particular family under a long-lasting close clinical follow-up.</p>
<p id="Par4">We took the advantage of a unique multiplex 22q11.2DS family with high load of psychosis expression (Fig. <xref ref-type="fig" rid="Fig1">1</xref>) and attempted to identify “second hits” that may contribute to psychosis and SZ developing, using bioinformatic analysis of whole-exome sequencing (WES) and comparative-genomic hybridization (CGH) array.<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>The analysis process designed for identifying molecular variants that may contribute to SZ-spectrum disorders in a multiplex 22q11.2DS family.</bold> Filled symbols indicate 22q11.2DS affected person with the same 22q11.2 deletion (CGH-array: chr22:18,844,632-21,703,145, GRCh37). *No DNA was available for these family members. BPE brief psychotic episode, CGH comparative-genomic hybridization, CNV copy number variation, DD delusional disorder, MLPA multiplex ligation probe amplification, SZ schizophrenia</p></caption><graphic id="d29e391" xlink:href="41398_2018_354_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Subjects</title>
<p id="Par5">The multigeneration Jewish family of Moroccan origin, consisted of a grandmother (mother side), parents and 8 children, referred to the Behavioral Neurogenetics Center with suspected 22q11.2DS in one of the children (VC621). Genetic assessment has demonstrated that VC621, her mother and three of her seven siblings are affected with 22q11.2DS (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). All family members with 22q11.2DS had psychiatric manifestations with varying degrees of severity, including specific and social anxiety disorder, generalized anxiety disorder (GAD), attention deficit/ hyperactivity disorder (ADHD), and SZ-spectrum disorders, including SZ, delusional disorder (DD), and history of brief psychotic episode (BPE) (Supplementary Table <xref ref-type="media" rid="MOESM1">1</xref>).</p>
<p id="Par6">The SZ-VC625 patient was hospitalized at the age of 25 years due to an acute psychotic episode that was triggered by use of 3,4-methylenedioxymethamphetamine (MDMA) and heroin. He was diagnosed with paranoid SZ and substance use disorder. Since then he suffers from chronic psychotic symptoms and marked negative symptoms with poor response to antipsychotics and he is currently living in a sheltered home. VC624 was diagnosed as suffering from a DD at the age 43. VC629 was diagnosed at the age 12 with ADHD, GAD, specific and social anxiety disorders and experienced a BPE at age 14. Unfortunately, no DNA was available for the sibling VC620 (Fig. <xref ref-type="fig" rid="Fig1">1</xref>) and therefore she was not included in the molecular analyses.</p>
</sec>
<sec id="Sec4">
<title>Psychiatric and cognitive assessments</title>
<p id="Par7">The participants were interviewed by experienced clinicians using the Structured Clinical Interview for Axis I DSM-IV Disorders (SCID)<sup><xref ref-type="bibr" rid="CR7">6</xref></sup>. The ADHD module from the Schedule for Affective Disorders and Schizophrenia for School-Aged Children, Present and Lifetime<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> was added to the SCID to evaluate the presence of ADHD. Cognitive evaluation was conducted with the age appropriate versions of the Wechsler Intelligence Scale<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. The study protocol was approved by the Sheba Medical Center Review Board. Written informed consent was obtained from all participants after the nature of this study was explained to the subjects.</p>
</sec>
<sec id="Sec5">
<title>Molecular testing for 22q11.2 microdeletion</title>
<p id="Par8">To confirm 22q11.2 microdeletion all family members with suspicious 22q11.2DS phenotype were tested by fluorescence in situ hybridization (FISH), using the LSI TUPLE1 (<italic>HIRA</italic>) or N25 commercial probes (Vysis Inc., Downers Grove, IL, USA), and by multiplex ligation probe amplification (MLPA) using SALSA MLPA P250-A1 DiGeorge kit (MRC-Holland, Amsterdam, Netherlands) analyses. In addition comparative-genomic hybridization (CGH) analysis, using Illumina HumanOmni Express-12 v 1.1 BeadChip (Illumina Inc, San Diego, CA) was conducted for all 10 family members (grandmother, parents and 7 children).</p>
</sec>
<sec id="Sec6">
<title>Genotyping in 22q11.2 region</title>
<p id="Par9"><italic>COMT</italic> Val158Met polymorphism (rs4680) was genotyped by the C25746809-50 TaqMan kit (Applied Biosystems Incorporated, Foster City, CA) using the ABI 7000 instrument. The genotyping of the seven additional SNPs from <italic>COMT-ARVCF</italic> region (rs2097603, rs4633, rs4818, rs3838146, rs165599, rs2073748, rs2240717) is described in our previous study<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> and the three short tandem repeats (STRs) markers (D22S1648, D22S941, and D22S944) were genotyped by Morrow et al.<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> and Perez et al.<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. The genotyping of the two <italic>PRODH</italic> functional SNPs rs2008720 and rs4819756 were described in our previous studies<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. The additional nine <italic>PRODH</italic> SNPs from exon 12 (rs16983466, rs2238731, rs2904552, rs2904551, rs3970559, rs2238730, rs2904550, rs2870984, and rs2870983) were performed by PCR amplification of a 452 bp fragment (primers: F-5′gggacagaggttggaggc-3′; R- 5′ggacacatgtggctgacaag-3′) followed by sequencing with BigDye Terminators using an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, USA).</p>
</sec>
<sec id="Sec7">
<title>Whole-exome sequencing (WES) analysis</title>
<p id="Par10">WES analysis of genomic DNA from 7 family members (parents and five of their children, which four of them are 22q11.2DS affected), was conducted by EdgeBio Company (EgdeBio, Gaithersburg, MD). Exon capture was performed with the Nimblegen SeqCap EZ Human Exome v3 (Roche NimbleGen, Madison, Wisconsin, USA). Paired end library was constructed using the Illumina TruSeq Sample Prep. Exon libraries were sequenced with the Illumina Hiseq 2000 platform (Illumina, San Diego, California, USA), providing about 100 bp read length for each sample with theoretical average coverage—100×. Variant tools<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> “bwa_gatk28_hg19” pipeline which followed the “Best GATK (v2.8-1-g932cd3a) practice” was used for read alignment and variant calling. Briefly, sequencing data were aligned to the human reference genome build 37 using the Burrows Wheeler Alignment tool (BWA 0.7.7) with default parameters. Duplicated reads were marked with Picard tool (<ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link>), and local realignment of reads around indels was performed in order to avoid misalignments due to indels. Next, base quality scores were recalibrated in order to get more accurate base qualities, which in turn improve the accuracy of the variant calls. Raw variants were called with the GATK’s UnifiedGenotyper following SNP and indels recalibration process which assigned a well-calibrated probability to each variant call. Filtering was done based on this score, and only variant calls which assigned the “PASS” filter (see GATK documentation for more details) were considered in downstream analysis. Variants were annotated against the single nucleotide polymorphism database (dbSNPs v.138), the 1000 Genome database and the RefSeq database.</p>
</sec>
<sec id="Sec8">
<title>Bioinformatic databases and tools</title>
<p id="Par11">The analysis of the WES data started from 1,215,052 variants, including exonic, 5′/3′ UTR, intergenic, intragenic and splice-sites. Filtering for only exonic variations revealed 27,988 variants out of which 13,854 were nonsynonymous.</p>
<p id="Par12">The validation of WES results for selected candidate variants were performed using SNP genotyping using the Sequenom Mass Array platform<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> and Sanger sequencing. Seven SNPs within the 22q11.2 were validated using TaqMan and RFLP analysis methods.</p>
<p id="Par13">Predicted level of variant penetrance was obtained using SIFT (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and Polyphen (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. VarElect (<ext-link ext-link-type="uri" xlink:href="http://varelect.genecards.org/">http://varelect.genecards.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, DisGeNET (<ext-link ext-link-type="uri" xlink:href="http://www.disgenet.org/web/DisGeNET/menu">http://www.disgenet.org/web/DisGeNET/menu</ext-link>)<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, and Schizophrenia Exome Sequencing Genebook<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> were also used to characterize variations. All genomic data for molecular variants in this study were compatible with Genome build GRCh37. NCBI gene database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gene">https://www.ncbi.nlm.nih.gov/gene</ext-link>), Ensembl<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, Exome aggregation consortium (ExAC)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, Vertebrate Genome Annotation database (Vega; <ext-link ext-link-type="uri" xlink:href="http://vega.sanger.ac.uk/index.html">http://vega.sanger.ac.uk/index.html</ext-link>)<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, and UCSC (<ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu/">https://genome.ucsc.edu/</ext-link>)<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> were used for genome builds and general gene and SNP (rs ID) annotations.</p>
<p id="Par14">Database of genomic variants (DGV; <ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca/dgv/app/home">http://dgv.tcag.ca/dgv/app/home</ext-link>)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> and Integrative Genomics Viewer (IGV; <ext-link ext-link-type="uri" xlink:href="http://software.broadinstitute.org/software/igv/">http://software.broadinstitute.org/software/igv/</ext-link>)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> were used for SNP analysis. Functional and pathway of specific genes resulting from WES and CGH-array were analyzed using DAVID (The Database for Annotation, Visualization and Integrated Discovery) Functional Annotation Bioinformatics Microarray Analysis (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/">https://david.ncifcrf.gov/</ext-link>)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. KEGG database was used to investigate biological pathways<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>.</p>
<p id="Par15">Protein–protein interaction analysis of selected genes was performed using STRING database (<ext-link ext-link-type="uri" xlink:href="http://string-db.org/">http://string-db.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and GeneMania (<ext-link ext-link-type="uri" xlink:href="http://genemania.org/">http://genemania.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>.</p>
</sec>
</sec>
<sec id="Sec9" sec-type="results">
<title>Results</title>
<sec id="Sec10">
<title>De novo and inherited rare CNVs contribution</title>
<p id="Par16">CGH-array analysis was performed for searching of de novo and rare CNVs and determination of the deletion borders in 10 family members (Fig. <xref ref-type="fig" rid="Fig1">1</xref>) using Illumina HumanOmni Express-12 v 1.1 BeadChip. Fifteen CNVs were detected in this family (Supplementary Table <xref ref-type="media" rid="MOESM1">2</xref>). De novo CNVs (17q21.31-gain and 11q14.1-loss) were identified only in the SZ-VC625 individual. Out of the 13 parental CNVs, rare paternal 3p26.3-loss (DGV<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> frequency 0.06%) was transmitted to all 22q11.2DS offspring and another one, rare maternal 14q11.2-gain (DGV frequency 0.09%), to the SZ sibling. Relatively high rates of parental CNVs were found in the SZ-VC625 (5/13) and DD-VC624 (7/13) siblings in comparison to their non-psychotic sister (1/13) (Supplementary Table <xref ref-type="media" rid="MOESM1">2</xref>).</p>
</sec>
<sec id="Sec11">
<title>22q11.2-haplotype association with psychosis</title>
<p id="Par17">To examine the association between 22q11.2 intact region and psychosis, we performed haplotype analysis using 73 polymorphisms from the deleted region (chr22:18,900,750-21,350,369; GRCh37): 51 variants, covered by WES and filtered by GATK “PASS” filter (see Materials and methods), and 22 additional variants by TaqMan, PCR, RFLP and Sanger sequencing. The haplotype analysis revealed transmission of a “risk” haplotype from the father to the three psychotic offspring, while the putative “protective” haplotype was transmitted to their non-psychotic daughter. These two haplotypes differed in 42 polymorphic sites out of the 73 (Supplementary Table <xref ref-type="media" rid="MOESM1">3</xref>). The “risk” haplotype encompassed two “damaging” variants, <italic>PRODH</italic>-rs2904552/T and <italic>CLTCL1</italic>-rs1061325/C, that are located on histone binding site, including H3K27me3 and H3K36me3 modifications (<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org/">http://www.mutationtaster.org/</ext-link>)<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. These two variants were not presented in the non-psychotic mother (VC622) and daughter (VC621) that carried different haplotypes (Supplementary Table <xref ref-type="media" rid="MOESM1">3</xref>).</p>
</sec>
<sec id="Sec12">
<title>SZ gene-set and putative pathways suggested by WES and CGH-array bioinformatic analysis</title>
<p id="Par18">To search for de novo, rare/damaging variants, common to the three psychotic siblings as well as those unique for SZ-VC625 bioinformatic selection analysis (PolyPhen2<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and SIFT<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> tools) of 1,215,052 WES variants were conducted using recessive, de novo, and Venn tool models. The results of the bioinformatic selection are presented in Supplementary Tables <xref ref-type="media" rid="MOESM1">4</xref> and <xref ref-type="media" rid="MOESM1">5</xref>. Following the bioinformatics selection, a further screening was conducted by examining the overlap with gene-sets established by eleven WES<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR37">37</xref></sup> studies in SZ, including 22q11.2DS-related SZ<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, and autism spectrum disorder (ASD)<sup><xref ref-type="bibr" rid="CR38">38</xref>–<xref ref-type="bibr" rid="CR41">41</xref></sup> (Supplementary Table <xref ref-type="media" rid="MOESM1">6</xref>). The putative genetic contributors that were common to the three psychotic siblings and unique for SZ individual in the studied family, based on WES-bioinformatic selection and CGH-array are presented in a Venn diagram with emphasis on the rare (≤0.05) and de novo variants (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Genetic contributors to SZ-spectrum disorders in the 22q11.2DS family.</title><p>Genes with damaging variants that are common to the three psychotic siblings as well as those unique to the SZ sibling are presented. The damaging variants were selected using SIFT and Polyphen2 prediction (Supplementary Table <xref ref-type="media" rid="MOESM1">4</xref> and <xref ref-type="media" rid="MOESM1">5</xref>) and overlapping with gene-set of 11 whole-exome sequencing studies in SZ and autism spectrum disorder populations (Supplementary Table <xref ref-type="media" rid="MOESM1">6</xref>). Genes with rare (≤0.05) variants, excluding de novo and CNVs, are bolded and presented in rates. BPE brief psychotic episode, DD delusional disorder, OR olfactory receptor genes, <italic>OR4K1, OR4K2, OR4K5, OR4K15, OR4M1, OR4N2</italic>, and <italic>OR4Q3</italic>, covered 14q11.2-gain, SZ schizophrenia</p></caption><graphic id="d29e749" xlink:href="41398_2018_354_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec13">
<title>Candidates common to the psychosis phenotype</title>
<p id="Par19">CGH-array identified a 3p26.3 rare deletion (DGV)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> transmitted from the father to the three psychotic siblings. This CNV includes <italic>CNTN4</italic> gene that has a role in formation of axon connections, neuronal network formation/plasticity and synaptogenesis in the developing nervous system (GeneCards: <ext-link ext-link-type="uri" xlink:href="https://www.genecards.org/">https://www.genecards.org/</ext-link>). In addition, 14 variants with damaging prediction (SIFT and Polyphen2) were selected as common to psychosis phenotype by WES-bioinformatic analysis (Supplementary Table <xref ref-type="media" rid="MOESM1">4</xref>). Five of them (36%), located in <italic>ACSF2</italic>, <italic>MPRIP</italic>, <italic>PER3</italic>, <italic>PHC1</italic>, and <italic>RERE</italic> genes, were rare variants (Fig. <xref ref-type="fig" rid="Fig2">2</xref>, Supplementary Table <xref ref-type="media" rid="MOESM1">4</xref>). <italic>RERE</italic> and <italic>PER3</italic> are located in the same 1p36.23 locus. <italic>RERE</italic> and <italic>PHC1</italic> are transcriptional repressors involved in chromatin organization and histone modifications during embryonic development. <italic>PHC1</italic> is associated with microcephaly and intellectual disability (DisGeNET). <italic>PER3</italic> is also a transcription factor that involved in circadian entrainment. Three keratin intermediate filament candidate genes (<italic>KRT13</italic>, <italic>KRT32</italic>, and <italic>KRT40</italic>, Fig. <xref ref-type="fig" rid="Fig2">2</xref>), clustered on 17q21, also related to circadian entrainment superpathway. Interestingly, <italic>ACSF2</italic> that involved in fatty acyl-CoA biosynthesis is located on the same 17q21 locus. Another cytoskeleton-related candidate, <italic>MPRIP</italic>, regulates disassembly of stress fibers in neuronal cells (GeneCards).</p>
</sec>
<sec id="Sec14">
<title>Candidates for SZ phenotype and pathway enrichments</title>
<p id="Par20">In addition to the candidates common for psychosis phenotype, we attempted to identify genetic factors unique to the SZ patient. Using de novo, recessive and Venn tool models additional variants with damaging SIFT/Polyphen2 predictions were selected (Supplementary Table <xref ref-type="media" rid="MOESM1">5</xref>). De novo CNVs, as described in the above section, were detected only in the SZ-VC625 sibling. Interestingly, 17q21.31-gain is located on 17q21 region that covered candidate genes common to psychotic siblings, namely, <italic>ACSF2</italic> and keratin genes. In addition, two de novo missense mutations, located in the <italic>DNAH7</italic> and <italic>KRT6C</italic> genes, were detected in the SZ sibling (Supplementary Table <xref ref-type="media" rid="MOESM1">5</xref>). All bioinformatically selected genetic contributors, including de novo and heritable, common to psychosis phenotypes and unique to SZ, are presented in the Fig. <xref ref-type="fig" rid="Fig2">2</xref>. As presented in this figure, the rate of the heritable rare variants (excluding CNV variants) that were unique for the SZ sibling was 52% (14/27), whereas the rate of the rare variants common to the three psychotic siblings was 36% (5/14).</p>
<p id="Par21">The 120 candidates selected for the SZ sibling (Supplementary Table <xref ref-type="media" rid="MOESM1">6</xref>), including 28 genes from the 22q11.2 deleted region and 82 additional from the entire genome, were used for running the DAVID<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> functional enrichment analysis. The statistically significant DAVID functional enrichments are presented in Fig. <xref ref-type="fig" rid="Fig3">3</xref> (details in Supplementary Table <xref ref-type="media" rid="MOESM1">7</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>DAVID functional candidate genes enrichment for the SZ patient.</title><p>Only genes with de novo and rare (≤0.05) variants are presented. Full list of bioinformatically selected candidates are presented in Supplementary table <xref ref-type="media" rid="MOESM1">7</xref>. Genes with variants, unique for SZ-VC625, are colored in blue. <italic>p</italic>-value for enrichment: *<italic>p</italic> ≤ 0.05; **<italic>p</italic> ≤ 0.01; ***<italic>p</italic> ≤ 0.005; ****<italic>p</italic> ≤ 0.00001<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. functional enrichments remained significant following Benjamini correction. GPCR G-protein coupled receptor, OR olfactory receptor genes contained rare variants unique to the SZ sibling: <italic>OR6C76</italic> and seven additional, <italic>OR4K1, OR4K2, OR4K5, OR4K15, OR4M1, OR4N2</italic> and <italic>OR4Q3</italic>, covered 14q11.2-gain</p></caption><graphic id="d29e911" xlink:href="41398_2018_354_Fig3_HTML"></graphic></fig></p>
<p id="Par22">Three signaling pathways, including transmembrane signaling receptor activity, detection of stimulus involved in sensory perception and olfactory transduction remained significant (<italic>p</italic> &lt; 0.04) following Benjamini correction for multiple testing. The G-protein-coupled receptor (GPCR) signaling and activity also revealed significant results (<italic>p</italic> &lt; 0.009) but did not survive after post hoc correction. Additional significant DAVID clustering identified neurodevelopmental pathways, including cranial nerve development/morphogenesis and neuron projection extension/morphogenesis. It is of note that the majority (~80%) of the genes enriched for sensory perception, olfactory transduction, and GPCR signaling were consisted of genes unique to the SZ patient, while the majority (75–88%) of the genes contributing to neurodevelopmental processes, including neuron projection extension/morphogenesis, were common to the psychosis phenotype (Supplementary Table <xref ref-type="media" rid="MOESM1">7</xref>).</p>
<p id="Par23">The histone modification processes did not appear to be significantly enriched by DAVID analysis. However, genes involved in these process included de novo (<italic>KANSL1</italic>) and inheritable (<italic>CNTN4, RERE</italic>, <italic>NCOA3</italic>, and <italic>PHC1</italic>) rare mutations (Supplementary Table <xref ref-type="media" rid="MOESM1">7</xref>). Specifically, <italic>RERE</italic>, <italic>PHC1</italic> and <italic>CNTN4</italic> variants were common to the three psychotic siblings and <italic>KANSL1</italic> and <italic>NCOA3</italic> variants were unique for SZ patient. In addition, fatty acyl-CoA biosynthesis and charge relay system processes, which involved in histone acylation and deacethylation, revealed DAVID statistical significance (<italic>p</italic> = 0.02 and <italic>p</italic> = 0.03, respectively) (Supplementary Table <xref ref-type="media" rid="MOESM1">7</xref>).</p>
</sec>
</sec>
<sec id="Sec15" sec-type="discussion">
<title>Discussion</title>
<p id="Par24">The goal of this study was to search for “second hits” that may contribute to the development of psychosis and SZ in a unique multiplex family with high load of psychotic expression affected by the inherited 22q11.2 deletion.</p>
<sec id="Sec16">
<title>Candidates common to psychosis phenotype</title>
<p id="Par25">Firstly, the putative contribution of the 22q11.2 intact chromosome to psychosis phenotype was examined. In the analyzed pedigree, one of the interesting finding is that the same haplotype in the 22q11.2 region is transmitted by the unaffected father to each of the three psychotic offspring. The corresponding 22q11.2-haplotype analysis revealed an association between a specific “risk” haplotype, contained two “damaging” variants in <italic>PRODH</italic> and <italic>CLTCL1</italic> genes, and psychosis. The identified rare and damaging <italic>PRODH</italic>-rs2904552 variant as well as <italic>CLTCL1</italic> de novo mutation were previously reported to be associated with SZ<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>. The <italic>CLTCL1</italic> has a role in synaptic plasticity (KEGG:hsa04721), neural crest development<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, neuronal depolarization<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, and histone modification<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Two previous case–control studies reported that variants on the 22q11.2 intact chromosome are not major contributors to SZ<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> and psychosis<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. The haplotype analysis of large multiplex families, in contrast to case–control studies, enables to examine contribution of the 22q11.2 gene variants, inherited together as a haplotype, to psychosis using internal control for comparison that eliminates the need for population stratification.</p>
<p id="Par26">When a CNV is not de novo, the pedigree offers an opportunity to identify other genetic factors than the 22q11.2-loss, “second hits”, contributing to the transmission of psychosis. Bioinformatic analysis of WES and CGH-array data selected 15 common for psychosis phenotype damaging variants and 6 of them were rare mutations, including paternal 3p26.3-loss and 5 additional missense mutations located in <italic>ACSF2, MPRIP, PHC1</italic>, <italic>PER3</italic>, and <italic>RERE</italic> genes. It is of note that the identified candidates were previously reported to be involved in neurodevelopmental processes and to be associated with psychosis and SZ. The 3p26.3-loss, that covered <italic>CNTN4</italic>, was previously reported to be associated with psychosis in 22q11.2DS<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. <italic>CNTN4</italic> gene is involved in synaptic plasticity<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, prefrontal neuron-specific histone methylation<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, response to antipsychotics<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, and was implicated in both SZ<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> and autism<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. <italic>RERE</italic> and <italic>PER3</italic> are located on the 1p36.23, one of the reported 108 SZ-associated loci<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. <italic>RERE</italic> and <italic>PHC1</italic> are transcriptional repressors involved in chromatin organization and histone modifications during embryonic development. PER3 is a transcriptional factor that together with the three keratin genes, established as candidates to psychosis in the current study, is related to circadian entrainment superpathway, recently reported as an overlapped superpathway for SZ, ASD, and bipolar disorder (BD)<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Interestingly, four candidates for psychosis (three keratin genes and <italic>ACSF2</italic>), identified in the current study, are located on 17q21 locus that was suggested to be associated with SZ in a linkage study that analyzed 175 families with at least two siblings suffering from SZ/SZ-affective disorders<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>.</p>
</sec>
<sec id="Sec17">
<title>Candidates unique to SZ phenotype and functional enrichment</title>
<p id="Par27">The next step of the study focused on search for risk gene-set and putative pathways that may contribute to the development of SZ. The detection of de novo mutations in the SZ sibling including CNVs (17q21.31-gain and 11q14.1-loss) and missense mutations (<italic>DNAH7</italic> and <italic>KRT6C</italic>) supports a de novo mutational paradigm for SZ<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. The 17q21.31-gain may be a relevant SZ risk factor since it contains the neuronal chromatin modifier <italic>KANSL1</italic> gene<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> and causes microduplication syndrome expressed in psychomotor retardation, poor social interaction and intellectual disability<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. In addition, 17q21.31-gain was established in childhood onset SZ<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Notably, the 17q21 region was demonstrated in the present study to be associated as a risk region common to the three psychotic siblings and as discussed above was previously reported to be associated with SZ<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. The 11q14.1-loss did not contain coding genes, however in 1.6 Mb upstream to this loss a rare deletion was previously reported in a patient with sporadic SZ<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>, and the same region was found to be highly associated (LOD = 3.44) with BD in a linkage study<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>.</p>
<p id="Par28">DAVID<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> functional enrichment analysis that was performed for bioinformatically selected SZ gene-set, identified several statistically significant biological pathways and processes. Sensory perception and neuron projection extension/morphogenesis established in the current study are consistent with previously reported findings in 22q11.2DS-related SZ<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. The GPCR signaling and olfactory transduction pathways, revealed in the current study, were previously reported to be involved in idiopathic<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup> and early-onset<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> SZ, respectively.</p>
<p id="Par29">Histone modification process, implicated in SZ in a large (60,000 participants) GWAS study<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> did not appear to be significantly enriched by DAVID analysis, however, the candidate genes involved in this process were affected by rare de novo and inherited variants. These variants include CNVs covered two histone modification genes, <italic>KANSL1</italic><sup><xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup> (17q21.31-gain) and <italic>CNTN4</italic><sup><xref ref-type="bibr" rid="CR50">50</xref></sup> (3p26.3-loss), and missense mutations in <italic>RERE</italic>, <italic>NCOA3</italic> and <italic>PHC1</italic> genes. Moreover, “fatty acyl-CoA biosynthesis” and “charge relay system” processes, which were previously reported to be involved in histone acylation and deacethylation<sup><xref ref-type="bibr" rid="CR66">66</xref>,<xref ref-type="bibr" rid="CR67">67</xref></sup>, exhibited DAVID significant results.</p>
<p id="Par30">The major weakness of this study is the small sample size of the pedigree, which limits the potential of reaching statistical significance. However, the studied pedigree is unique multiplex 22q11.2DS family with high load of psychosis expression comprised of eight offspring which half of them inherited the maternal deletion. In addition, the fact that one of the three siblings was diagnosed with SZ enabled us to attempt to identify both, variants common to the psychosis phenotype as well as variants that are unique to the SZ individual.</p>
<p id="Par31">Thus, it appears that the strength of our pedigree design is that all cases share the same genetic causes identical by descent (IBD) that enabled the identification of molecular events relevant to the psychosis phenotype. Furthermore, the value of the pedigree is the exclusion of events not shared by all the affected offspring.</p>
<p id="Par32">We suggest that specific molecular events, CNVs and missense mutations, outside the 22q11.2, account for disruptions in neurodevelopmental processes, including neuron projection extension and morphogenesis, cytoskeleton signaling and histone modification, that may contribute to the psychosis phenotype in 22q11.2DS. Apparently, the combination of a larger load of damaging molecular events with greater harmful effects on neurodevelopmental processes, together with additional effects on sensory perception, olfactory transduction and GPCR signaling may explain development of SZ in 22q11.2DS. A future study including large 22q11.2DS families with SZ and non-SZ psychosis, as well as a comparison sample of large families with non-22q11.2DS SZ may help in establishing biological pathways relevant to the pathophysiology of SZ and may lead to the development of novel treatments.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec18">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41398_2018_354_MOESM1_ESM.docx"><caption><p>Supplementary Tables</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>These authors contributed equally: Elena Michaelovsky, Miri Carmel</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary Information</bold> accompanies this paper at (10.1038/s41398-018-0354-9).</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>This work is supported by the Brain &amp; Behavior Research Foundation (NARSAD: 22597), the Binational Science Foundation, Grant Number 2011378 and the National Institute of Mental Health of the National Institutes of Health under Award Number U01MH101722.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>E.M., M.C. and A.W. designed the project, carried out the molecular analyses, and prepared the first draft of the manuscript; D.G. performed the clinical characterization of the participants and collected the blood samples; M.P.-C. and M.S.-D. performed the bioinformatic analyses; E.M., M.C., A.F., A.W. and D.G. conceived the research approach and managed the preparation of the final draft.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Conflict of interest</title>
<p>The authors declare that they have no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects</article-title>
<source/>Nat. Genet.
          <year>2017</year>
<volume>49</volume>
<fpage>27</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3725</pub-id>
<pub-id pub-id-type="pmid">27869829</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A polygenic burden of rare disruptive mutations in schizophrenia</article-title>
<source/>Nature
          <year>2014</year>
<volume>506</volume>
<fpage>185</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1038/nature12975</pub-id>
<pub-id pub-id-type="pmid">24463508</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium.</collab>
</person-group>
<article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>
<source/>Nature
          <year>2014</year>
<volume>511</volume>
<fpage>421</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
<pub-id pub-id-type="pmid">25056061</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome</article-title>
<source/>Am. J. Psychiatry
          <year>2014</year>
<volume>171</volume>
<fpage>627</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2013.13070864</pub-id>
<pub-id pub-id-type="pmid">24577245</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<mixed-citation publication-type="other">Bassett, A. S. et al. Rare genome-wide copy number variation and expression of schizophrenia in 22q11.2 deletion syndrome. <italic>Am. J. Psychiatry</italic><bold>174</bold>, 1054–1063 (2017).</mixed-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufman</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data</article-title>
<source/>J. Am. Acad. Child Adolesc. Psychiatry
          <year>1997</year>
<volume>36</volume>
<fpage>980</fpage>
<lpage>988</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199707000-00021</pub-id>
<pub-id pub-id-type="pmid">9204677</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<mixed-citation publication-type="other">First, M. B., Spitzer, R. L., Gibbon, M. &amp; Williams, J. B. W. <italic>User’s Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version</italic> (American Psychiatric Press, Washington, D.C., 1997).</mixed-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<mixed-citation publication-type="other">Wechsler, D. &amp; Corporation, P. <italic>WISC-III: Wechsler Intelligence Scale for Children: Manual</italic>, (Psychological Corporation, San Antonio, TX, 1991).</mixed-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<mixed-citation publication-type="other">Wechsler, D. <italic>WAIS-III, Wechsler Adult Intelligence Scale: Administration and Scoring Manual</italic>, (Psychological Corporation, San Antonio, TX, 1997).</mixed-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michaelovsky</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS</article-title>
<source/>Int. J. Neuropsychopharmacol.
          <year>2008</year>
<volume>11</volume>
<fpage>351</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1017/S1461145707008085</pub-id>
<pub-id pub-id-type="pmid">17949513</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrow</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome</article-title>
<source/>Am. J. Hum. Genet.
          <year>1995</year>
<volume>56</volume>
<fpage>1391</fpage>
<lpage>1403</lpage>
<pub-id pub-id-type="pmid">7762562</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes)</article-title>
<source/>Curr. Opin. Pediatr.
          <year>2002</year>
<volume>14</volume>
<fpage>678</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="doi">10.1097/00008480-200212000-00005</pub-id>
<pub-id pub-id-type="pmid">12436034</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carmel</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects</article-title>
<source/>J. Psychiatr. Res.
          <year>2014</year>
<volume>56</volume>
<fpage>28</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2014.04.019</pub-id>
<pub-id pub-id-type="pmid">24853458</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarchi</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes</article-title>
<source/>J. Psychiatr. Res.
          <year>2013</year>
<volume>47</volume>
<fpage>1623</fpage>
<lpage>1629</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.07.004</pub-id>
<pub-id pub-id-type="pmid">23910792</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Leal</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Variant association tools for quality control and analysis of large-scale sequence and genotyping array data</article-title>
<source/>Am. J. Hum. Genet.
          <year>2014</year>
<volume>94</volume>
<fpage>770</fpage>
<lpage>783</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.04.004</pub-id>
<pub-id pub-id-type="pmid">24791902</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<mixed-citation publication-type="other">Gabriel, S., Ziaugra, L. &amp; Tabbaa, D. SNP genotyping using the Sequenom MassARRAY iPLEXplatform. <italic>Curr. Protoc. Hum. Genet</italic>. Chapter 2, Unit 2 (2009).</mixed-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>
<source/>Nat. Protoc.
          <year>2009</year>
<volume>4</volume>
<fpage>1073</fpage>
<lpage>1081</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2009.86</pub-id>
<pub-id pub-id-type="pmid">19561590</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>IA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A method and server for predicting damaging missense mutations</article-title>
<source/>Nat. Methods
          <year>2010</year>
<volume>7</volume>
<fpage>248</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
<pub-id pub-id-type="pmid">20354512</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stelzer</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>VarElect: the phenotype-based variation prioritizer of the GeneCards Suite</article-title>
<source/>BMC Genom.
          <year>2016</year>
<volume>17</volume>
<issue>Suppl 2</issue>
<fpage>444</fpage>
<pub-id pub-id-type="doi">10.1186/s12864-016-2722-2</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinero</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes</article-title>
<source/>Database
          <year>2015</year>
<volume>2015</volume>
<fpage>bav028</fpage>
<pub-id pub-id-type="doi">10.1093/database/bav028</pub-id>
<pub-id pub-id-type="pmid">25877637</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hubbard</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Ensembl genome database project</article-title>
<source/>Nucleic Acids Res.
          <year>2002</year>
<volume>30</volume>
<fpage>38</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1093/nar/30.1.38</pub-id>
<pub-id pub-id-type="pmid">11752248</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature
          <year>2016</year>
<volume>536</volume>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashurst</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The vertebrate genome annotation (Vega) database</article-title>
<source/>Nucleic Acids Res.
          <year>2005</year>
<volume>33</volume>
<fpage>D459</fpage>
<lpage>D465</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gki135</pub-id>
<pub-id pub-id-type="pmid">15608237</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<mixed-citation publication-type="other">Karolchik, D., Hinrichs, A. S. &amp; Kent, W. J. The UCSC genome browser. <italic>Curr. Protoc. Bioinformatics</italic> Chapter 1, Unit 14 (2009).</mixed-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacDonald</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Ziman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Feuk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>The database of genomic variants: a curated collection of structural variation in the human genome</article-title>
<source/>Nucleic Acids Res.
          <year>2014</year>
<volume>42</volume>
<fpage>D986</fpage>
<lpage>D992</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkt958</pub-id>
<pub-id pub-id-type="pmid">24174537</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>JT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrative genomics viewer</article-title>
<source/>Nat. Biotechnol.
          <year>2011</year>
<volume>29</volume>
<fpage>24</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id>
<pub-id pub-id-type="pmid">21221095</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang da</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>
<source/>Nat. Protoc.
          <year>2009</year>
<volume>4</volume>
<fpage>44</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id>
<pub-id pub-id-type="pmid">19131956</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanehisa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kawashima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Furumichi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>KEGG as a reference resource for gene and protein annotation</article-title>
<source/>Nucleic Acids Res.
          <year>2016</year>
<volume>44</volume>
<fpage>D457</fpage>
<lpage>D462</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv1070</pub-id>
<pub-id pub-id-type="pmid">26476454</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>STRINGv10: protein-protein interaction networks, integrated over the tree of life</article-title>
<source/>Nucleic Acids Res.
          <year>2015</year>
<volume>43</volume>
<fpage>D447</fpage>
<lpage>D452</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gku1003</pub-id>
<pub-id pub-id-type="pmid">25352553</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warde-Farley</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function</article-title>
<source/>Nucleic Acids Res.
          <year>2010</year>
<volume>38</volume>
<fpage>W214</fpage>
<lpage>W220</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkq537</pub-id>
<pub-id pub-id-type="pmid">20576703</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seelow</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>MutationTaster2: mutation prediction for the deep-sequencing age</article-title>
<source/>Nat. Methods
          <year>2014</year>
<volume>11</volume>
<fpage>361</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.2890</pub-id>
<pub-id pub-id-type="pmid">24681721</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sim</surname>
<given-names>NL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SIFT web server: predicting effects of amino acid substitutions on proteins</article-title>
<source/>Nucleic Acids Res.
          <year>2012</year>
<volume>40</volume>
<fpage>W452</fpage>
<lpage>W457</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gks539</pub-id>
<pub-id pub-id-type="pmid">22689647</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fromer</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>
<source/>Nature
          <year>2014</year>
<volume>506</volume>
<fpage>179</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1038/nature12929</pub-id>
<pub-id pub-id-type="pmid">24463507</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guipponi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Correction: exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<fpage>e0141630</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0141630</pub-id>
<pub-id pub-id-type="pmid">26488584</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCarthy</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability</article-title>
<source/>Mol. Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>652</fpage>
<lpage>658</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.29</pub-id>
<pub-id pub-id-type="pmid">24776741</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole-genome sequencing suggests schizophrenia risk mechanisms in humans with 22q11.2 deletion syndrome</article-title>
<source/>G3
          <year>2015</year>
<volume>5</volume>
<fpage>2453</fpage>
<lpage>2461</lpage>
<pub-id pub-id-type="doi">10.1534/g3.115.021345</pub-id>
<pub-id pub-id-type="pmid">26384369</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exome sequencing supports a de novo mutational paradigm for schizophrenia</article-title>
<source/>Nat. Genet.
          <year>2011</year>
<volume>43</volume>
<fpage>864</fpage>
<lpage>868</lpage>
<pub-id pub-id-type="doi">10.1038/ng.902</pub-id>
<pub-id pub-id-type="pmid">21822266</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo gene disruptions in children on the autistic spectrum</article-title>
<source/>Neuron
          <year>2012</year>
<volume>74</volume>
<fpage>285</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.009</pub-id>
<pub-id pub-id-type="pmid">22542183</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neale</surname>
<given-names>BM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<fpage>242</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="doi">10.1038/nature11011</pub-id>
<pub-id pub-id-type="pmid">22495311</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<fpage>246</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1038/nature10989</pub-id>
<pub-id pub-id-type="pmid">22495309</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations revealed by whole-exome sequencing are strongly associated with autism</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<fpage>237</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1038/nature10945</pub-id>
<pub-id pub-id-type="pmid">22495306</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulsuner</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network</article-title>
<source/>Cell
          <year>2013</year>
<volume>154</volume>
<fpage>518</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.06.049</pub-id>
<pub-id pub-id-type="pmid">23911319</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacquet</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PRODH mutations and hyperprolinemia in a subset of schizophrenic patients</article-title>
<source/>Hum. Mol. Genet.
          <year>2002</year>
<volume>11</volume>
<fpage>2243</fpage>
<lpage>2249</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/11.19.2243</pub-id>
<pub-id pub-id-type="pmid">12217952</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nahorski</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch development</article-title>
<source/>Brain
          <year>2015</year>
<volume>138</volume>
<fpage>2147</fpage>
<lpage>2160</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awv149</pub-id>
<pub-id pub-id-type="pmid">26068709</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chahrour</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism</article-title>
<source/>PLoS Genet.
          <year>2012</year>
<volume>8</volume>
<fpage>e1002635</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002635</pub-id>
<pub-id pub-id-type="pmid">22511880</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinstein</surname>
<given-names>JS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes</article-title>
<source/>Blood
          <year>2014</year>
<volume>124</volume>
<fpage>3719</fpage>
<lpage>3729</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2014-06-582700</pub-id>
<pub-id pub-id-type="pmid">25331115</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guipponi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients</article-title>
<source/>Transl. Psychiatry
          <year>2017</year>
<volume>7</volume>
<fpage>e1039</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.258</pub-id>
<pub-id pub-id-type="pmid">28221368</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>HJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schizophrenia two-hit hypothesis in velo-cardio facial syndrome</article-title>
<source/>Am. J. Med. Genet. B
          <year>2013</year>
<volume>162B</volume>
<fpage>177</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32129</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landek-Salgado</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Faust</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Molecular substrates of schizophrenia: homeostatic signaling to connectivity</article-title>
<source/>Mol. Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>10</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2015.141</pub-id>
<pub-id pub-id-type="pmid">26390828</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shulha</surname>
<given-names>HP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human-specific histone methylation signatures at transcription start sites in prefrontal neurons</article-title>
<source/>PLoS Biol.
          <year>2012</year>
<volume>10</volume>
<fpage>e1001427</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1001427</pub-id>
<pub-id pub-id-type="pmid">23185133</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Jamba</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Patrick</surname>
<given-names>C</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Padmanabhan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study</article-title>
<source/>Pharmacogenomics
          <year>2012</year>
<volume>13</volume>
<fpage>1227</fpage>
<lpage>1237</lpage>
<pub-id pub-id-type="doi">10.2217/pgs.12.105</pub-id>
<pub-id pub-id-type="pmid">22920393</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<fpage>e67776</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0067776</pub-id>
<pub-id pub-id-type="pmid">23922650</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glessner</surname>
<given-names>JT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism genome-wide copy number variation reveals ubiquitin and neuronal genes</article-title>
<source/>Nature
          <year>2009</year>
<volume>459</volume>
<fpage>569</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="doi">10.1038/nature07953</pub-id>
<pub-id pub-id-type="pmid">19404257</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<mixed-citation publication-type="other">Khanzada, N. S., Butler, M. G. &amp; Manzardo, A. M. Gene analytics pathway analysis and genetic overlap among autism spectrum disorder, bipolar disorder and schizophrenia. <italic>Int. J. Mol. Sci.</italic><bold>18</bold>, E527 (2017).</mixed-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escamilla</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A schizophrenia gene locus on chromosome 17q21 in a new set of families of Mexican and central american ancestry: evidence from the NIMH Genetics of schizophrenia in latino populations study</article-title>
<source/>Am. J. Psychiatry
          <year>2009</year>
<volume>166</volume>
<fpage>442</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2008.08040612</pub-id>
<pub-id pub-id-type="pmid">19188284</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girard</surname>
<given-names>SL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased exonic de novo mutation rate in individuals with schizophrenia</article-title>
<source/>Nat. Genet.
          <year>2011</year>
<volume>43</volume>
<fpage>860</fpage>
<lpage>863</lpage>
<pub-id pub-id-type="doi">10.1038/ng.886</pub-id>
<pub-id pub-id-type="pmid">21743468</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Strong association of de novo copy number mutations with sporadic schizophrenia</article-title>
<source/>Nat. Genet.
          <year>2008</year>
<volume>40</volume>
<fpage>880</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="doi">10.1038/ng.162</pub-id>
<pub-id pub-id-type="pmid">18511947</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koolen</surname>
<given-names>DA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome</article-title>
<source/>Nat. Genet.
          <year>2012</year>
<volume>44</volume>
<fpage>639</fpage>
<lpage>641</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2262</pub-id>
<pub-id pub-id-type="pmid">22544363</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Natacci</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chromosome 17q21.31 duplication syndrome: description of a new familiar case and further delineation of the clinical spectrum</article-title>
<source/>Eur. J. Paediatr. Neurol.
          <year>2016</year>
<volume>20</volume>
<fpage>183</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2015.09.010</pub-id>
<pub-id pub-id-type="pmid">26565673</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High rate of disease-related copy number variations in childhood onset schizophrenia</article-title>
<source/>Mol. Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>568</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.59</pub-id>
<pub-id pub-id-type="pmid">23689535</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fanous</surname>
<given-names>AH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic overlap of schizophrenia and bipolar disorder in a high-density linkage survey in the Portuguese Island population</article-title>
<source/>Am. J. Med. Genet. B
          <year>2012</year>
<volume>159B</volume>
<fpage>383</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32041</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity</article-title>
<source/>Mol. Psychiatry
          <year>2017</year>
<volume>22</volume>
<fpage>417</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.98</pub-id>
<pub-id pub-id-type="pmid">27457813</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered expression of mRNA profiles in blood of early-onset schizophrenia</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>16767</fpage>
<pub-id pub-id-type="doi">10.1038/srep16767</pub-id>
<pub-id pub-id-type="pmid">26733343</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<mixed-citation publication-type="other">Network &amp; Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. <italic>Nat. Neurosci.</italic><bold>18</bold>, 199–209 (2015).</mixed-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meunier</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An epigenetic regulator emerges as microtubule minus-end binding and stabilizing factor in mitosis</article-title>
<source/>Nat. Commun.
          <year>2015</year>
<volume>6</volume>
<fpage>7889</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms8889</pub-id>
<pub-id pub-id-type="pmid">26243146</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finnin</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</article-title>
<source/>Nature
          <year>1999</year>
<volume>401</volume>
<fpage>188</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1038/43710</pub-id>
<pub-id pub-id-type="pmid">10490031</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabari</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Allis</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Metabolic regulation of gene expression through histone acylations</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <year>2017</year>
<volume>18</volume>
<fpage>90</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="doi">10.1038/nrm.2016.140</pub-id>
<pub-id pub-id-type="pmid">27924077</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>